{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:04:51Z","timestamp":1780405491442,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N022556\/1"],"award-info":[{"award-number":["MR\/N022556\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["108766\/Z\/15\/Z"],"award-info":[{"award-number":["108766\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>1\u20132% of pregnancies are ectopic, the majority implanting in the Fallopian tube. A single, systemic dose of methotrexate, a DNA-synthesis (S phase) inhibitor, has been used since 1991 for outpatient treatment of women with stable EP. However, methotrexate has limited clinical and cost effectiveness, restricting its use to 25\u201330% of these women. There is an unmet need for better medical treatment for EP. Colony stimulating factor-1 (CSF-1) promotes placentation and creates a pro-inflammatory environment that is fundamental for the maintenance of a normal pregnancy. We hypothesised that CSF-1 is also involved in the placentation and maintenance of an EP. Herein, we demonstrate the immunolocalisation of the CSF-1 receptor (CSF-1R) as well as its ligand (CSF-1) in immortalised first trimester trophoblast cells. We show that a specific CSF-1R kinase inhibitor, GW2580, abolishes CSF-1 induced trophoblast cell proliferation and migration and can be cytotoxic. We then demonstrate the expression of CSF-1R and CSF-1 in the cytotrophoblast and syncytiotrophoblast within ectopic implantation sites from women with EP. Our data suggests that CSF-1 is involved in the survival and proliferation of trophoblast cells in EP. This suggests that pharmacological disruption of CSF-1\/CSF-1R signaling axis could be the basis of a new therapeutic for EP.<\/jats:p>","DOI":"10.1038\/s41598-020-72785-y","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T10:04:50Z","timestamp":1600941890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Targeting colony stimulating factor-1 receptor signalling to treat ectopic pregnancy"],"prefix":"10.1038","volume":"10","author":[{"given":"S. Furquan","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Colin","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa L.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn E.","family":"Beaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Koscielniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa T. K.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Horne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,24]]},"reference":[{"key":"72785_CR1","doi-asserted-by":"publisher","first-page":"d3397","DOI":"10.1136\/bmj.d3397","volume":"342","author":"D Jurkovic","year":"2011","unstructured":"Jurkovic, D. & Wilkinson, H. Diagnosis and management of ectopic pregnancy. BMJ 342, d3397. https:\/\/doi.org\/10.1136\/bmj.d3397 (2011).","journal-title":"BMJ"},{"key":"72785_CR2","first-page":"693","volume":"112","author":"FA Taran","year":"2015","unstructured":"Taran, F. A. et al. The diagnosis and treatment of ectopic pregnancy. Dtsch. Arztebl. Int. 112, 693\u2013703 (2015).","journal-title":"Dtsch. Arztebl. Int."},{"key":"72785_CR3","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/humrep\/dep438","volume":"25","author":"R Shao","year":"2010","unstructured":"Shao, R. Understanding the mechanisms of human tubal ectopic pregnancies: new evidence from knockout mouse models. Hum. Reprod. 25, 584\u2013587 (2010).","journal-title":"Hum. Reprod."},{"key":"72785_CR4","doi-asserted-by":"publisher","first-page":"902426","DOI":"10.1155\/2015\/902426","volume":"2015","author":"F Sendy","year":"2015","unstructured":"Sendy, F. et al. Failure rate of single dose methotrexate in managment of ectopic pregnancy. Obstet. Gynecol. Int. 2015, 902426 (2015).","journal-title":"Obstet. Gynecol. Int."},{"key":"72785_CR5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3109\/00016349.2010.486825","volume":"89","author":"ES Guvendag Guven","year":"2010","unstructured":"Guvendag Guven, E. S. et al. Comparison of single and multiple dose methotrexate therapy for unruptured tubal ectopic pregnancy: a prospective randomized study. Acta Obstet. Gynecol. Scand. 89, 889\u2013895 (2010).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"72785_CR6","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1017\/erm.2011.2","volume":"14","author":"AW Horne","year":"2012","unstructured":"Horne, A. W. & Critchley, H. O. Mechanisms of disease: the endocrinology of ectopic pregnancy. Expert Rev. Mol. Med. 14, e7 (2012).","journal-title":"Expert Rev. Mol. Med."},{"issue":"4","key":"72785_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1136\/jfprhc-2011-0073","volume":"37","author":"VN Sivalingam","year":"2011","unstructured":"Sivalingam, V. N., Duncan, W. C., Kirk, E., Shephard, L. A. & Horne, A. W. Diagnosis and management of ectopic pregnancy. J. Fam. Plann. Reprod. Health Care 37(4), 231\u2013240 (2011).","journal-title":"J. Fam. Plann. Reprod. Health Care"},{"key":"72785_CR8","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1177\/0049475517700810","volume":"47","author":"S Ngwenya","year":"2017","unstructured":"Ngwenya, S. Challenges in the surgical management of ectopic pregnancy in a low-resource setting: Mpilo Central Hospital Bulawayo Zimbabwe. Trop. Doct. 47, 316 (2017).","journal-title":"Trop. Doct."},{"key":"72785_CR9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.bpobgyn.2008.12.009","volume":"23","author":"M Agdi","year":"2009","unstructured":"Agdi, M. & Tulandi, T. Surgical treatment of ectopic pregnancy. Best Pract. Res. Clin. Obstet. Gynaecol. 23, 519\u2013527 (2009).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"72785_CR10","first-page":"192","volume":"108","author":"MC Sowter","year":"2001","unstructured":"Sowter, M. C., Farquhar, C. M., Petrie, K. J. & Gudex, G. A randomised trial comparing single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured tubal pregnancy. BJOG 108, 192\u2013203 (2001).","journal-title":"BJOG"},{"key":"72785_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4161\/cbt.26718","volume":"15","author":"Y Yang","year":"2014","unstructured":"Yang, Y. et al. M-CSF cooperating with NFkappaB induces macrophage transformation from M1 to M2 by upregulating c-Jun. Cancer Biol. Ther. 15, 99\u2013107 (2014).","journal-title":"Cancer Biol. Ther."},{"key":"72785_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1677\/joe.0.1590069","volume":"159","author":"GS Hamilton","year":"1998","unstructured":"Hamilton, G. S., Lysiak, J. J., Watson, A. J. & Lala, P. K. Effects of colony stimulating factor-1 on human extravillous trophoblast growth and invasion. J. Endocrinol. 159, 69\u201377 (1998).","journal-title":"J. Endocrinol."},{"key":"72785_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jri.2015.01.005","volume":"109","author":"M Rahmati","year":"2015","unstructured":"Rahmati, M. et al. Colony Stimulating Factors 1, 2, 3 and early pregnancy steps: from bench to bedside. J. Reprod. Immunol. 109, 1\u20136 (2015).","journal-title":"J. Reprod. Immunol."},{"key":"72785_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S0015-0282(01)01859-3","volume":"76","author":"U von Rango","year":"2001","unstructured":"von Rango, U. et al. Effects of trophoblast invasion on the distribution of leukocytes in uterine and tubal implantation sites. Fertil. Steril. 76, 116 (2001).","journal-title":"Fertil. Steril."},{"key":"72785_CR15","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3389\/fncel.2018.00368","volume":"12","author":"YN Gerber","year":"2018","unstructured":"Gerber, Y. N. et al. CSF1R inhibition reduces microglia proliferation, promotes tissue preservation and improves motor recovery after spinal cord injury. Front. Cell Neurosci. 12, 368 (2018).","journal-title":"Front. Cell Neurosci."},{"key":"72785_CR16","doi-asserted-by":"publisher","first-page":"e0137515","DOI":"10.1371\/journal.pone.0137515","volume":"10","author":"AL Leblond","year":"2015","unstructured":"Leblond, A. L. et al. Systemic and cardiac depletion of M2 macrophage through CSF-1R signaling inhibition alters cardiac function post myocardial infarction. PLoS ONE 10, e0137515 (2015).","journal-title":"PLoS ONE"},{"key":"72785_CR17","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.1158\/0008-5472.CAN-14-3373","volume":"75","author":"DL Moughon","year":"2015","unstructured":"Moughon, D. L. et al. Macrophage blockade using CSF1R inhibitors reverses the vascular leakage underlying malignant ascites in late-stage epithelial ovarian cancer. Cancer Res. 75, 4742\u20134752 (2015).","journal-title":"Cancer Res."},{"key":"72785_CR18","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/brain\/awv379","volume":"139","author":"A Olmos-Alonso","year":"2016","unstructured":"Olmos-Alonso, A. et al. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer\u2019s-like pathology. Brain 139, 891\u2013907 (2016).","journal-title":"Brain"},{"key":"72785_CR19","doi-asserted-by":"publisher","first-page":"8818","DOI":"10.1073\/pnas.86.22.8818","volume":"86","author":"RJ Arceci","year":"1989","unstructured":"Arceci, R. J., Shanahan, F., Stanley, E. R. & Pollard, J. W. Temporal expression and location of colony-stimulating factor 1 (CSF-1) and its receptor in the female reproductive tract are consistent with CSF-1-regulated placental development. Proc. Natl. Acad. Sci. USA 86, 8818\u20138822 (1989).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72785_CR20","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/330484a0","volume":"330","author":"JW Pollard","year":"1987","unstructured":"Pollard, J. W. et al. Apparent role of the macrophage growth factor, CSF-1, in placental development. Nature 330, 484\u2013486 (1987).","journal-title":"Nature"},{"key":"72785_CR21","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3109\/10799899309073690","volume":"13","author":"I Athanassakis-Vassiliadis","year":"1993","unstructured":"Athanassakis-Vassiliadis, I., Papamatheakis, J. & Vassiliadis, S. Specific CSF-1 binding on murine placental trophoblasts and macrophages serves as a link to placental growth. J. Recept. Res. 13, 739\u2013751 (1993).","journal-title":"J. Recept. Res."},{"key":"72785_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/bs.ctdb.2016.10.004","volume":"123","author":"V Chitu","year":"2017","unstructured":"Chitu, V. & Stanley, E. R. Regulation of embryonic and postnatal development by the CSF-1 receptor. Curr. Top. Dev. Biol. 123, 229\u2013275 (2017).","journal-title":"Curr. Top. Dev. Biol."},{"key":"72785_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0897.1997.tb00268.x","volume":"38","author":"K Katano","year":"1997","unstructured":"Katano, K. et al. Low serum M-CSF levels are associated with unexplained recurrent abortion. Am. J. Reprod. Immunol. 38, 1\u20135 (1997).","journal-title":"Am. J. Reprod. Immunol."},{"key":"72785_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0015-0282(02)03240-5","volume":"78","author":"A Lindhard","year":"2002","unstructured":"Lindhard, A. et al. Biochemical evaluation of endometrial function at the time of implantation. Fertil. Steril. 78, 221\u2013233 (2002).","journal-title":"Fertil. Steril."},{"key":"72785_CR25","doi-asserted-by":"publisher","first-page":"16078","DOI":"10.1073\/pnas.0502000102","volume":"102","author":"JG Conway","year":"2005","unstructured":"Conway, J. G. et al. Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580. Proc. Natl. Acad. Sci. USA 102, 16078\u201316083 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72785_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ebiom.2016.02.024","volume":"6","author":"RB Holmgaard","year":"2016","unstructured":"Holmgaard, R. B., Zamarin, D., Lesokhin, A., Merghoub, T. & Wolchok, J. D. Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors. EBioMedicine 6, 50\u201358 (2016).","journal-title":"EBioMedicine"},{"key":"72785_CR27","doi-asserted-by":"publisher","first-page":"e2002979","DOI":"10.1371\/journal.pbio.2002979","volume":"16","author":"Y Zur","year":"2018","unstructured":"Zur, Y. et al. A dual-specific macrophage colony-stimulating factor antagonist of c-FMS and alphavbeta3 integrin for osteoporosis therapy. PLoS Biol. 16, e2002979 (2018).","journal-title":"PLoS Biol."},{"key":"72785_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ebiom.2018.02.020","volume":"29","author":"SF Ahmad","year":"2018","unstructured":"Ahmad, S. F. et al. Pelvic chlamydial infection predisposes to ectopic pregnancy by upregulating integrin beta1 to promote embryo-tubal attachment. EBioMedicine 29, 159\u2013165 (2018).","journal-title":"EBioMedicine"},{"key":"72785_CR29","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/AOG.0b013e3182a1ba56","volume":"122","author":"UW Nilsson","year":"2013","unstructured":"Nilsson, U. W. et al. Effects of gefitinib, an epidermal growth factor receptor inhibitor, on human placental cell growth. Obstet. Gynecol. 122, 737 (2013).","journal-title":"Obstet. Gynecol."},{"key":"72785_CR30","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/AOG.0b013e3182a14cfb","volume":"122","author":"MM Skibisz","year":"2013","unstructured":"Skibisz, M. M. et al. Combination gefitinib and methotrexate compared with methotrexate alone to treat ectopic pregnancy. Obstet. Gynecol. 122, 745 (2013).","journal-title":"Obstet. Gynecol."},{"key":"72785_CR31","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.placenta.2009.08.007","volume":"30","author":"SL Straszewski-Charez","year":"2009","unstructured":"Straszewski-Charez, S. L. et al. The isolation and characterization of a novel telomerase immortalized first trimester trophoblast cell line, Swan 71. Placenta 30, 939 (2009).","journal-title":"Placenta"},{"key":"72785_CR32","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1182\/blood-2018-03-838946","volume":"133","author":"DK Edwards","year":"2018","unstructured":"Edwards, D. K. et al. CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells. Blood 133, 588 (2018).","journal-title":"Blood"},{"key":"72785_CR33","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.14440\/jbm.2016.132","volume":"3","author":"AR Dwyer","year":"2016","unstructured":"Dwyer, A. R., Ellies, L. G., Holme, A. L. & Pixley, F. J. A three-dimensional co-culture system to investigate macrophage-dependent tumor cell invasion. J. Biol. Methods 3, e49 (2016).","journal-title":"J. Biol. Methods"},{"key":"72785_CR34","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/j.fertnstert.2016.02.003","volume":"105","author":"B Peng","year":"2016","unstructured":"Peng, B. et al. Gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor are expressed at tubal ectopic pregnancy implantation sites. Fertil. Steril. 105, 1620 (2016).","journal-title":"Fertil. Steril."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72785-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72785-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72785-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T19:20:05Z","timestamp":1670354405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72785-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,24]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["72785"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-72785-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,24]]},"assertion":[{"value":"15 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AWH has received consultancy fees from Roche Diagnostics, Abbvie, Nordic Pharma and Ferring. WCD has spoken at meetings supported by Guerbet and Merck. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15638"}}